.svg){kind=icon}
IQVIA
Sitemap
-
Articles
-
A Day in the Life of a Human Data Scientist
-
A Day in the Life of a Human Data Scientist Not Your Standard Statistics and Analytics
-
A five-step approach for optimising established brands portfolio value
-
A review of the current R D landscape of RNA therapeutics
-
A Sponsors Perspective Why Digital Adoption Lags in Clinical Trials
-
A unified approach to supplier quality management
-
Accelerate Development of New Oncology Therapies with FDAs Project FrontRunner
-
Accelerating Precision in Life Science Marketing
-
AccessPoint issue 14
-
Achieving Faster Simpler Validation Through Crowdsource UAT
-
Achieving Launch Excellence in the Evolving Obesity Market
-
Addressing Biosimilar Clinical Trial Challenges with the IQVIA Biosimilar Site Network
-
Addressing The Challenges Of Enterprise Wide Performance Insights
-
Adjusting to a New Normal
-
Advancing a Framework for Regulatory Use of Real World Evidence
-
AI-focused Biopharma Partnerships Drive Transformation of R and D
-
AIML Transforming Patient Support in the Digital Age
-
Alzheimers Disease An Update on Treatment Options and Pipeline Developments
-
Alzheimers Disease A Burgeoning Market on the Horizon
-
An analysis of requests for information in EU combined clinical trials
-
An Evolving Landscape in Life Sciences
-
An Inflection Point in Obesity R and D
-
An Update on Key Selected Pipeline Developments
-
An Update on Treatment Options and Pipeline Developments for Type 1 and 2 Diabetes
-
An Update on Treatment Options and Pipeline Developments for Type 2 Diabetes
-
Applying Cutting-Edge Technologies to Improve Global Participant Payment Paradigms
-
Better balance of cancer treatment efficacy and toxicity
-
Beyond Patent Protection Generics Driving Market Trajectories
-
Beyond the Protocol
-
Beyond Weight Loss
-
BioSpectrum Asia Healthcare M and A Outlook Bright in 2018
-
Boost Compliance By Monitoring Social Media
-
Breakthrough Technologies Drive Upsurge in CNS Dealmaking
-
Bridging Borders IQVIAs Expertise in Global Clinical Trial Management
-
CAR-T Cell Therapy in Cancer Treatment
-
Cell and Gene R and D in Cancer Care Increasing Patient Access
-
Challenging Market and Economic Conditions Drove Dealmaking Slowdown in Q1 2023
-
Chinas Outbound Pharma Partnering Deals Gain Momentum
-
Clinical Trial Data Strategy
-
Complex Dynamics in the Heart Failure Market
-
COVID-19 the Next Wave of Vaccines and Therapeutics
-
Crowdsource UAT An Opportunity for Future Validation
-
Data-Driven Adaptive Trials Enhancing Safety Accelerating Progress and Boosting Economics
-
DCTs are our genie in the bottle
-
Decoding HCP Behavior
-
Defining the Future of Quality and Regulatory Operations in MedTech
-
Dermatology Drives Autoimmune Market Growth
-
Digital Health A New Path to Success
-
Digital Health Connecting the Digital Dots
-
Drive Engagement by Creating a Truly Personalized Patient Experience
-
Emerging Compliance Monitoring Trends in Life Sciences
-
Emerging Dealmaking Trends in Gene Therapy
-
Empowering QARA Professionals Through AI Driven Digital Transformation
-
Enhancing Participant Payments
-
Ensuring R and D Investments Deliver Maximum Potential
-
Environmental Sustainability in Pharma
-
Essential Steps for Intelligent Document Processing in Clinical Trials
-
Establishing AI in MedTech A Strategic Blueprint for QARA Leaders
-
Evidence driven spatiotemporal COVID-19 hospitalization prediction with Ising dynamics
-
Executive Summary Investigator Payments A Critical Component in Bayers Sponsor of Choice Strategy
-
Fair Market Value is Not A Request Its A Law
-
From Advantage to Essential
-
From Compliance to Competitive Edge
-
From fragmented to focused
-
From Signatures to Success
-
Global QMS Digitization in MedTech Navigating the SME Journey
-
Got a question about your study status
-
Harnessing Information across the Enterprise
-
Horizon Scanning Universal Healthcare in South Africa
-
How AI is Shaping Key and Digital Opinion Leader Identification
-
How are IVD Medical Devices classified in EU
-
How Do Differences in Cancer Types Lead to Differences in Cancer Treatments
-
How ensuring your content engages with your audience
-
How Transformative Technology Can Help Life Sciences Companies Reach HCPs
-
Improving R and D Efforts Clinical Trial Advancements to Watch in 2024
-
Increase commercial effectiveness with strategic outsourced solutions
-
Intelligently Automating Safety and Regulatory Processes
-
IQVIA Pharma Deals Review 2024
-
IQVIA Pharma Deals Review 2024 open
-
IRT The Unsung Hero of Modern Trials
-
Key Developments and Trends in the Middle East and African Pharmaceutical Markets
-
Key Opportunities and Challenges in the Nordic Pharmaceutical Markets
-
Key Tailwinds and Headwinds Impacting the Major Developed Markets
-
Key Tailwinds and Headwinds Impacting the Outlook for the Asian Pharmaceutical Market
-
KRAS Mutation An Update on Key Selected Pipeline Developments and Clinical Trials
-
Latest Developments in CRISPR and Genome Editing Clinical Trials
-
Level Up Your Supply Chain Initiatives
-
Licensing Down in H1 2023 as Dealmakers Remain Cautious
-
Life Science Companies React to Recent Changes in Meeting Related PhRMA Code Guidance
-
Living With a Rare Disease The Unique Considerations for Your Patient Support Program
-
M A Activity Shows Early Signs of Recovery in Q3 2024
-
M and A Activity Rebounds at the End of 2023
-
M and A Activity Slows in 2022 as the Pandemic Biotech Boom Fades
-
M and A Deal Values Soar in Q1 2024
-
M and A Deals Dwindle in Late 2024
-
Mastering Rare Disease Launch Excellence MedAdNews
-
Mastering Rare Disease Launch Excellence PharmaLive
-
Maximize your asset value across the biopharma value chain
-
Medical Device Recalls the significance of patient safety and brand integrity
-
mRNA Therapies in Oncology
-
Navigating Patient Consent Scenarios in COVID 19 Trials
-
Navigating the Intersection of Technology and Human Expertise in Life Sciences
-
Navigating the Shifting Landscape of Myasthenia Gravis Treatment
-
Next Best Success Factors for Deploying a Next Best Suggestion Program
-
Next Generation Site Identification
-
Next-Gen Patient Support Enhancing the Experience Using Data-Driven Personalization
-
Obesity Interest Sparks Dealmaking Activity
-
Obesity Key Pipeline Developments and Clinical Trial Insights
-
Obesity Market Revolution
-
Optimizing Product Lifecycle Management With Real-World Evidence
-
Optimizing Talent for a Winning Omnichannel Approach
-
Orphan Drug Exclusivity A Lifeline for Rare Disease Patients
-
Overview of the Active Pharmaceutical Ingredient Market
-
Parkinsons disease An Analysis on Key Selected Pipeline Developments and Clinical Trial Insights
-
Pharma CX: The Solution Lies in Converging Silos
-
PharmaExec The Future of Pharmacovigilance and Regulation Management
-
PharmaVoice What is Next Post COVID 19
-
Power Launch Excellence with Generative AI
-
Powering Launch Excellence with Patient Engagement and Support Systems
-
Preparing for the Changing Paradigm in Data Management
-
Preparing Your Data for AI at Global Scale
-
Real World Evidence Remains Essential for Rare and Ultra-Rare Disease Drug Development
-
Reducing Clinical Trial Burden How an Orchestrated IRT eCOA Solution Helps
-
Reducing Costs and Accelerating Time-to-Market for Medical Devices
-
Reducing Waste with Intelligent Automation Accelerates Clinical Trial Success
-
Regulatory Data Protection in Switzerland
-
Reimagining Medical Device Innovation Through Integrated Intelligence
-
Revolutionizing Personalized Medicine
-
Sanofi Revolutionizes Pharmacovigilance with Project ARTEMIS
-
Simplifying Clinical Trials Addressing Technology Challenges for Site Teams
-
Strategic Acquisitions Fuel MA Deal Values in Q3 2025
-
Surge in ADC Deals Drives Oncology Dealmaking
-
Sustainability in Clinical Trials Purposeful Digitalization is Key
-
Take Advantage of Technology that Helps Pharma Reps Better Orchestrate Customer Engagement
-
The Advancement and Challenges in HIV Treatment
-
The EU AI Act Will Regulation Drive Life Science Innovation Away from Europe
-
The Evolution of Field Team Orchestration in an AI World
-
The Future of Launch Excellence is Generative AI
-
The High Five Key Regulatory Topics for Drug Development in 2024
-
The High IQ Approach of Human Data Science
-
The Impact of AI on Quality Operations
-
The Realities of Patient Recruitment and Retention
-
Therapeutic Breakthroughs Drive Dealmaking in Endocrine and Metabolic Disorders
-
Think Tank Key Elements of Successful Launches
-
Tracking the evolution Data-driven insights in the maturing obesity treatment landscape
-
Trends in Clinical Development for PD1 PD L1 Inhibitors
-
Understanding the Opportunities and Challenges in Latin Americas Pharmaceutical Markets
-
Understanding the Surge in New Product Launches in Chinas Pharma Market
-
Using AI to Predict Launch Success
-
Using Tech Enabled Solutions to Boost Productivity and Sustainability in Clinical Trials
-
What is Behind the Robust Growth in the Global Oncology Market
-
Why face-to-face MSL engagement still matters in an AI-driven age
-
Why Integrated Clinical Trial Financial Management is Critical for Trial Success
-
Year End 2022 Review of Key Pharma R and D Events
-
-
Brochures
-
Compliance Monitoring Take your program from policing to a proactive partnership
-
Discover 9 Key Insights for Life Sciences Commercial Models
-
Discover the Power of IQVIAs MedTech Market Monitor
-
e Pharmacy Thrives as OTC Growth Begins Recovery
-
Epilepsy Clinical Trials
-
Harness the True Value of Your Healthcare Data for Driving Business Insights
-
How Can Smarter Sample Collection Empower Patient-Centric Trials
-
IQVIA Biostatistics
-
IQVIA Clinical eSource Platform
-
IQVIA Complete Consent
-
IQVIA Consumer Health Thriving in post COVID 19 world Consumer Behavior
-
IQVIA Consumer Health Thriving in post COVID 19 world Commercial Execution
-
IQVIA Consumer Health Thriving in post COVID 19 world Data Accessibility
-
IQVIA Consumer Health Thriving in post COVID 19 world Innovation Pipeline and Launch Strategy
-
IQVIA Consumer Health Thriving in post COVID 19 world Marketing
-
IQVIA Consumer Health Thriving in post COVID-19 world Evolving ways of working
-
IQVIA Consumer Health Thriving in post COVID-19 world RandD
-
IQVIA Functional Service Provider Models
-
IQVIA Marketing Services
-
IQVIA MedTech Consulting Capabilities
-
IQVIA One Home for Sites
-
IQVIA Patient Engagement and Support
-
IQVIA Strategic Meetings and Events
-
IQVIAs Drug Discovery Development Services
-
IVDR Essentials How to adapt to the upcoming IVDR
-
Medical Device Trial Integration
-
New Solutions for Advancing How We Understand and Treat Alzheimers Disease
-
The Future of Healthcare Professional Engagement
-
-
Case Studies
-
A Geographic Roll-out Plan in the Rare Disease Space
-
Accelerating Market Expansion with End-to End HCPO Engagement Services
-
AI-Enabled Weekly Triggers from IQVIAs Alerts program
-
Biovacs Drive for Innovation Partnering with IQVIA to Advance Healthcare
-
Building a Compliance Program from the Ground Up
-
Case Study Education and Support for Caregivers
-
CDC Analysis of Extensive Data Sets and Insight into Obesity Trends and Related Health Issues
-
Client Case Study Improving Predictive Precision of Oncology Patient Modeling with Enriched Data
-
Client Case Study Optimizing Rare Disease Field Engagement
-
Closing Data Gaps
-
Confirming marketing ROI for a mature brand in the oncology space
-
CRO InClin Simplifies Budgeting and Site Negotiations with GrantPlan
-
Digital Promotion Hub for High-Equity Established Brands
-
Driving Global Impact in Ophthalmology Generics
-
Empowering FDA Clearance for AI Triage Technology in Stroke Detection Under 60 Days
-
Empowering Patients at Scale
-
Engagement and Greater MSL Confidence with Expert Ecosystem
-
Enhancing Physician Segmentation and Targeting with a Patient-Centric Approach
-
Ensuring Timely and Accurate EU-CTR Submissions
-
From Insight to Action
-
From Volume to Value
-
Impact of NAFLD on the Incidence of Cardiovascular Diseases in a Primary Care Population
-
Integration of IRT and eConsent with Unified Delivery Provides Robust Solutions
-
Intuitive Software Eases Payments for Sites
-
IQVIA Accelerates Performance Excellence in Obesity Trials
-
IQVIA Alerts reduced Sales Reps lead to engagement
-
IQVIA eCOA Delivers on a Tight Timeline for a Sickle Cell Disease Study
-
IQVIA Linguistic Validation Delivers a Complex Cognitive Battery Project on a Tight Timeline
-
IQVIAs Analytics Research Accelerator
-
IRT and eClinical Technology Considerations for Cell and Gene Therapy
-
Maximising Activation and Adherence
-
Medical Devices Speaker Programs
-
Omnichannel PSP monitoring for safety events
-
Optimizing Patient Profiling Market Sizing
-
Recalibrating Go to Market Model for Established Brands
-
Removing Barriers Restoring Hope
-
Removing Barriers Restoring Well-being
-
Replacing Legacy Systems for Smarter Transparency Reporting
-
Revolutionizing Care for Stroke Patients
-
Safeguard Your Medical Devices Business with Smarter Channel Data Management
-
Solving Challenges in Trials for Ulcerative Colitis
-
StayHome Project Implementing Proximity Care for Multiple Sclerosis Patients
-
Strategic Outsourcing to Optimize Established Brands
-
Streamlining Audio Data for Adverse Event Detection
-
The Story of Implementing the Next-Gen Customer MDM at Novartis
-
Transform Your Medical Devices Contract Management with IQVIA MedTech 845 Automation
-
Transforming Oncology Research IQVIAs End-to-End Patient Experience Data Approach
-
Translating Clinical Information Faster Whilst Ensuring Quality
-
Unlocking Market Expansion with Precise Disease-Segmented Strategies
-
Weekly Triggers from IQVIAs Alerts Program
-
A portfolio approach to early clinical development
-
Accurately Measuring Pertussis with GP-EMR RWD
-
Adapting to COVID-19 Adjudication and Oversight Group Management
-
Adding Virtual Engagement Improved Sales By Over 95
-
Advanced Patient Finding and Disease Modeling
-
AI Case Study How IQVIA Increased Target Patient Identification 15X
-
AI Powered Modeling Finds Potentially Non Adherent Patients for Outreach
-
Dynamic HCP Profiling and Targeting AI-Powered Precise HCP Segmentation Improves Results
-
Alnylam Puts Sites and Patients First with IQVIA Technologies Investigator Site Portal
-
Analyzing treatment pathways and drug persistence for oral antidiabetic drugs
-
Assessing Unmet Needs in Treating Severe Asthma in Poland
-
Bayer and IQVIA harmonize global healthcare data at scale
-
Building confidence in ibuprofen safety amidst the uncertainty of the COVID 19 pandemic
-
Cardiovascular Device Company Exceeds Patient Enrollment Goals Six Months Ahead of Schedule
-
Case Study Download Respiratory Treatment Research
-
Change Management Lays the Groundwork for Smooth Overhaul of Compliance Platform
-
Client Case Study Revealing the Treatment Landscape and Patient Pathways in a new Market
-
Compassionate Protocol-Required Study Support
-
Complex digital transformation of an EDC
-
Complex Workflow and Data Collection through IQVIA Research Management Platform
-
Critical Milestones Achieved Ahead of Schedule in Lung Cancer Study
-
CS Next Best Boosting Sales Performance
-
Custom eCOA Library Accelerates Oncology Program Timelines
-
Data in a Day
-
DETECT SPOTLIGHT
-
Driving Growth Field Alerts Transform Pharma Strategy
-
Dynamic HCP Profiling and Targeting
-
Effective Launch and Strategic Partnership
-
Enabling In App Specialist Location and Evaluation for Digital Patient Communities
-
Enrollment Surpasses Projections in International Psoriasis Studies
-
Enterprise Information Management Purpose Built for Pharma
-
Establishing Hepatic Carcinoma Treatment Patterns and Disease Burden in China
-
Exceeding Growth by Rapid Turnaround
-
Fast-Tracking Clinical Trials
-
Full Service Expertise Efficiently Drives Success of Pivotal
-
Global Cardiovascular Medical Device Rescue Trial
-
Global Transparency Reporting
-
Healthcare Insights Through AI and Machine Learning
-
High Volume Patient Narratives When Agile Solutions And Expertise Matter Most
-
How Emerging Biopharma Companies Can Successfully Launch Their Asset
-
How to Generate Business Insights in Rare Diseases and Niche Oncology Through Data Triangulation
-
Human Data Science and Adverse Event Reporting
-
Human Data Science and Antibiotic Overprescribing
-
Human Data Science and Medication Adherence
-
Human Data Science and Mental Health
-
Human Data Science and Personalized Medicine
-
Human Data Science and Social Determinants
-
Improving Launch by Identifying and Profiling the Most Relevant KOLs
-
Identifying Relevant Dual-Skill Key Opinion Leaders via a Single Unified Platform
-
Improving Patient Identification 95x with AI-Powered Modeling
-
Improving Patient Profiling and Physician Targeting
-
Incidence of adverse cardiovascular events in patients with acute myocardial infarction
-
Increase Online HCP Outreach Without Compliance Risks
-
Increased Value and Efficiency through a Consolidated Functional Resourcing Provider FSP Model
-
Increasing Therapy Starts Though AI Powered Precise Patient Identification Field Alerts
-
Increasing User Engagement with New Healthcare Provider Search Module
-
Integrated PV Tech and Services Solution Case Study
-
Intelligent IRT Design Process for COVID-19 Trials Accelerates Digital Enablement at Sites
-
Investigator Payments A Critical Component in Bayers Sponsor of Choice Strategy
-
IQVIA Generated Evidence China
-
IQVIA Improves Efficiencies and Delivers Consistent Quality with Integrated FSP Model
-
IQVIA Investigator Site Portal An Enterprise Implementation
-
IQVIA Remote Detailing Case Study Abiogen Pharma
-
IQVIA Vigilance Detect Voice
-
Large scale analysis of dual combination therapies
-
Largest real-world evidence study on Heavy Menstrual Bleeding
-
LEGEND Hypertension
-
Leveraging Expertise to Exceed Immunotherapy Customer Goals
-
Meeting Global Transparency Reporting Requirements
-
Menopausal women and vasomotor symptoms
-
Mid size Pharma Reduced Time to Identify and Qualify Data Sources by 80
-
Navigating Treatment Outcomes
-
NLP Big Data Analytics For Population Health
-
NLP Closing Care Gaps using Social Determinants of Health
-
NLP examining rare disease biology Text Mining At Takeda
-
NLP Generating brand insights social media ai
-
Nlp How Agios Uses Text Mining For Automated Identification Of Potential Drug Safety Events
-
Nlp how csl behring uses to improve meddra coding
-
NLP How Roche Patient Insights Social Media
-
NLP IQVIA Health Data Transformation Solutions Integrate With Clients Big Data Platform
-
NLP Midwestern Academic Medical Center Achieves Deep Phenotyping For Precision Medicine
-
NLP Top 10 Pharma Creates Clinical Trial Benchmarks
-
NLP Using AI for Deep Data Extraction
-
OMOP analysis supports EMA bid
-
Oncology Clinical Trials RFP Planning Guide
-
Oncology Expertise Facilitates Accelerated Timeline
-
Operationalizing 30 minute ECG review
-
Optimizing Pharmaceutical Sales Force Effectiveness
-
Overcoming the Challenges of Managing Regulatory Information
-
Patient and HCP Targeting with ML
-
Patient Finder Identifying Asthma Patients with Oral Corticosteroid Use
-
Patient Finder Identifying Patients with Cardiac Amyloidosis
-
powered prediction of high-risk of exacerbation in asthma sub-groups for improved patient care
-
Precise HCP Segmentation Raised Patient Identification 16x
-
Predicting future cost burden of patients with type 2 diabetes mellitus in the US and Europe
-
Predictive Field Alerts Driving Rx Lift and ROI in Autoimmune Treatment
-
Preventing Early Drug Discontinuation
-
Pushing for Brand Leadership
-
Race To Market Study Surpasses Diversity and Enrollment Goals
-
Real Time Data Cleaning When Urgency Matters
-
Reducing Time to Launch Evidence Generation by Streamlining Data Source Qualification
-
Regulatory Review of Promotional Materials for an EU based Pharmaceutical Company
-
Retrospective cohort characterization of COVID-19 infected patients that received remdesivir
-
Retrospective safety database audits
-
Revolutionizing Health Data Integration Access and Research
-
RWE OMOP results showed that emerging therapy just effective traditional type 2 diabetes treatment
-
Single System for TOV Data
-
Targeted Recruitment Campaign Fulfills Enrollment Targets
-
The OMOP Retainer
-
The smart use of an innovative approach helped Pfizer expand its addressable market
-
Top 10 Global Pharma Company Dramatically Improves Site Payments
-
Top Pharma Company Drives Growth with Insight Orchestration
-
Transitioning to Global Transparency
-
Dynamic HCP Profiling and Targeting Unlocking Growth with AI and Machine Learning
-
Using In depth Oncology Market Insights to Build Successful and Dynamic Launch Plans
-
Using RWD to Establish the Need for a New Treatment
-
Vigilance Detect Case Study Brochure
-
-
Fact Sheets
-
5 Steps to a Reliable CAPA Process
-
Accelerate Your Obesity Trials With IQVIAs Solutions And Expertise
-
Access 10-Year Sales Value and Volume Forecasts
-
Access granular patient numbers to truly understand market dynamics in your market
-
Access to Budgeting Intelligence
-
Achieve harmony at last with IQVIA Harmonized Quality
-
Achieve Unsurpassed Preparedness Transparency and Agility with IQVIA eTMF Solutions
-
Advancing Respiratory Research An Integrated Approach to Clinical Trials
-
Advisor System Integrator Partner Program Fact Sheet
-
AI Clinical Decision Support Tools Fact Sheet
-
Analyze the Japanese Market with the MDV Hospital Database
-
Australian GP-EMR Primary Care Dataset
-
Automate and Accelerate Health Data Transformation
-
Balancing Compliance Among the Shifting Sands of Pharmaceutical Data Privacy Regulations
-
Big Data Transfer Tool
-
Biomedical Global Data OnDemand
-
CDAS-Analytics as a Service
-
Cenduit Interactive Response Technology
-
Centralized User Acceptance Testing
-
China Regional Electronic Health Records rEHR Data Fact Sheet
-
China Regional Electronic Health Records rEHR Dataset
-
Clalit Health Services Israel
-
Clinical Data Analytics Solutions
-
Clinical Trial Analytics Services
-
Clinical Trial Disclosure Services
-
Clinical Trial Payments Fact Sheet
-
Commercial Outsourcing Services
-
Comparative evidence for EU HTA
-
Connected Devices Fact Sheet Advancing Glucose Data Collection
-
Connecting Data to Insights to Actions
-
Consumer-centric claims through virtual research
-
COVID Diary Item Banks
-
COVID19 Continues to Impact Global Spending on Medicines
-
Customer Journey Analytics
-
Data as a Service
-
Data Bridging
-
Data Management Real-Time Data Cleaning
-
Data Privacy, Consent Collection and Management Solution (A4)
-
Dedicated European Regulatory Solutions for MedTech Companies
-
Device utilization electronic survey
-
Digital Health Evidence Generation
-
Digital Patient Suite
-
Digital Planning Suite
-
Digital Site Suite
-
Digital Trial Management Suite
-
Drive Better Health Outcomes with Cloudera and IQVIA
-
Driving Safety and Compliance Seamlessly
-
E360 HEOR and Data Science Power Tools for Deep Insights from Data
-
Early Signal Prediction Platform
-
Easily View Historical and Predicted Loss-of-Protection Dates All in One Place
-
Electronic Clinical Outcome Assessment eCOA Solution Fact Sheet
-
Electronic Drug Accountability and Returns Management
-
End to End Safety Solutions
-
End-to-end eQMS for MedTech Use Cases
-
Enhance Remote Communication Skills for Healthcare Professional Engagement
-
Ensure JCA Success
-
Exceed Expectations in Quality Control with IQVIAs Risk-Based Validation
-
Expedite Your Early Phase Clinical Trial Decisions
-
Faster insights with IQVIA DaaS Snowflake
-
Faster Insights with IQVIA OneKey via Snowflake Data-as-a-Service
-
Flexible Design for Novel Trials
-
Flexible Outsourcing of commercial resources
-
Forecast Horizon
-
FSP Advance Trial Management and Direct to Patient solution
-
FSP Change Management Preparation for the journey ahead
-
Fully-Managed Cohort Characterization Fact Sheet
-
Gain a Deeper Understanding of Your Competitors Performance
-
Gain access to a standardized searchable view of the global clinical trial market
-
Gain Clear Insights Into Industry Pipelines and Plan For Your Product Success
-
Generating Real World Evidence Across the Total Product Lifecycle
-
Get Rich Insights with the Japanese Claims Plus2 Dataset
-
Get Your Tile into One Home for Sites
-
Global Scalable End to End Solutions for your Compliance and Engagement Challenges
-
Go beyond expectations with state of the art IQVIA Risk Based Monitoring
-
Good Clinical Practice
-
Good Manufacturing Practice
-
GrantPlan for Investigator Initiated Studies
-
Harness the Power of Conversational AI Prioritize the Voice of HCPs for Maximum Campaign Impact
-
Harnessing the Power of Real-World Evidence Across the Diagnostic Lifecycle
-
HCP Fair Market Value Solutions That are Simple Global and Defensible
-
How the Rapidly Evolving Regulatory Landscape Will Drive the Increasing Need for Post market
-
Incentive 360
-
Integrated Data Platform
-
IQVIA Agile Health Insights
-
IQVIA AI Management
-
IQVIA AI-Assisted Literature Review Service
-
IQVIA Analytics Research Accelerator
-
IQVIA Biobanking Solution
-
IQVIA CAR T-Cell Monitor
-
IQVIA Clinical Data Exchange
-
IQVIA Clinical eSource Platform
-
IQVIA Clinical Event Validation and Adjudication
-
IQVIA Clinical Expert Fact Sheet
-
IQVIA Clinical Trial Educators
-
IQVIA Clinical Trial Financial Suite
-
IQVIA Clinical Trial Financial Suite At A Glance
-
IQVIA Cohort Analytics
-
IQVIA Cohort Development
-
IQVIA Commercial Analytics Managed Services
-
IQVIA Commercial Compliance
-
IQVIA Commercial Compliance Consulting and Managed Services
-
IQVIA Commercial Technologies
-
IQVIA Connected Devices Ambulatory Blood Pressure Monitoring
-
IQVIA Connection Solution
-
IQVIA Consumer Health Innovation Tracker and Drivers of Growth
-
IQVIA Consumer Health Market Insights
-
IQVIA COVID19 Daily Diary and Weekly Diary Item Banks
-
IQVIA Data Profiling
-
IQVIA Data Query System
-
IQVIA Data Variability Analytics DVA
-
IQVIA Data-Informed Protocol Assessment
-
IQVIA Digital Expert
-
IQVIA Direct-to-Patient Recruitment
-
IQVIA eArchive Fact Sheet
-
IQVIA Early Phase Oncology Network
-
IQVIA eCOA
-
IQVIA Established Brands Optimization
-
IQVIA eTMF Essentials
-
IQVIA eTMF eUpload Feature Fact Sheet
-
IQVIA eTMF Expert Services
-
IQVIA eTMF Fact Sheet
-
IQVIA eTMF Fact Sheet Key Features
-
IQVIA Expert Ecosystem fact sheet
-
IQVIA Fair Market Value Services
-
IQVIA Feasibility
-
IQVIA Field Effectiveness
-
IQVIA Flex Outsourcing Solutions
-
IQVIA Forecasting
-
IQVIA FSP Advance Trial Design Planning and Management Powered by Clinical Trial Analytics
-
IQVIA FSP Staffing An Expert Extension of Your Team
-
IQVIA Global Clinical Data Management
-
IQVIA Global Market Insights Agent
-
IQVIA Global Medical Writing
-
IQVIA Global Regulatory Affairs
-
IQVIA Global Regulatory Affairs Covid-19
-
IQVIA GrantPlan Fact Sheet
-
IQVIA Grants and Funding Management
-
IQVIA HCP O Engagement Management Transforming HCP O engagement management globally
-
IQVIA HDSC Data Science Platform
-
IQVIA Health Data Access
-
IQVIA Health Data Catalog
-
IQVIA Health Data Catalog Deep Dives Fact Sheet
-
IQVIA Health Data Semantics Suite
-
IQVIA Health Preference Research
-
IQVIA Health Research Space
-
IQVIA HealthCare Authenticator Software Development Kit
-
IQVIA HealthCare Locator Software Development Kit
-
IQVIA Horizon Scanning
-
IQVIA Human Data Science Cloud
-
IQVIA Insights as a Service
-
IQVIA Inspection Readiness Program
-
IQVIA Integrated COA Solutions Licensing Linguistic Validation and eCOA Implementation
-
IQVIA Integrated Complete Consent IRT eCOA
-
IQVIA Integrated Field Alerts Solution
-
IQVIA Integrated Global Compliance Solutions
-
IQVIA Intelligent Document Review
-
IQVIA Intelligent eTMF
-
IQVIA Interactive Response Technology
-
IQVIA Investigator Site Portal
-
IQVIA Language Solutions Accelerating Clinical Trials Operations
-
IQVIA Learning Management System
-
IQVIA Literature AI Platform
-
IQVIA Medical Information Services Fact Sheet
-
IQVIA MedTech Global Data Insights Fact Sheet
-
IQVIA MedTech Recall and Field Action Program
-
IQVIA Next Best Action
-
IQVIA Next Best Fact Sheet
-
IQVIA NLP Platform for Quality Measures
-
IQVIA OMOP Converter
-
IQVIA Oncology Biomarker Monitor
-
IQVIA Oncology Dynamics
-
IQVIA Oncology Landscape Report
-
IQVIA Oncology Physician Insights
-
IQVIA OneKey Accelerated Insights
-
IQVIA OneKey Global Marketing Services
-
IQVIA Operational Data Exchange
-
IQVIA Orchestrated Analytics
-
IQVIA Participant Payments
-
IQVIA Patient and Disease Insights
-
IQVIA Patient Centricity in Design Fact Sheet
-
IQVIA Patient Finder Solution
-
IQVIA Patient Journey and Smart Targeting Platform
-
IQVIA Patient Portal
-
IQVIA Patient Recruitment and Enablement
-
IQVIA Patient Suite
-
IQVIA Peer Expert
-
IQVIA Productized Analytics Services
-
IQVIA Provider Insights
-
IQVIA Quality Compliance Consulting
-
IQVIA Quality Management and Regulatory Suite Fact Sheet
-
IQVIA Recruitment Insight Analytics
-
IQVIA Registry Platform
-
IQVIA Regulatory eSubmission Validator
-
IQVIA Regulatory Mapping
-
IQVIA Regulatory PDF Tools
-
IQVIA Regulatory Templates
-
IQVIA Remote Registered Dietitians
-
IQVIA Remote Research Clinicians
-
IQVIA RIM Smart for MedTech Fact Sheet
-
IQVIA Safety Notifications
-
IQVIA Scientific Expert Fact Sheet
-
IQVIA Sitezone
-
IQVIA SmartSolve Deviation Management
-
IQVIA SmartSolve RIM
-
IQVIA SmartSolve RIM Content Management for Pharma
-
IQVIA Speaker Bureau Services
-
IQVIA Statistical Programming
-
IQVIA Stem Cell Center FS
-
IQVIA Study Optimizer
-
IQVIA Targeted Site Analytics
-
IQVIA Technologies for Consumer Health
-
IQVIA Technologies Quality Management System
-
IQVIA Therapeutic breakthroughs
-
IQVIA Thought Leadership Virtual ISPOR Europe 2021
-
IQVIA TM HDSC PLATFORM AS A SERVICE PaaS
-
IQVIA Transparency Reporting
-
IQVIA Transparency Reporting A versatile and user friendly technology meeting
-
IQVIA Trial Manager Fact Sheet
-
IQVIA Vigilance Analytics Fact Sheet
-
IQVIA Vigilance Case
-
IQVIA Vigilance Collect
-
IQVIA Vigilance Detect
-
IQVIA Vigilance Detect for GLP-1 Therapies
-
IQVIA Vigilance Detect Transforming Pharmacovigilance with Measurable Outcomes
-
IQVIA Vigilance Detect Voice
-
IQVIA Vigilance Intake
-
IQVIA Vigilance Periodic
-
IQVIA Vigilance Platform Fact Sheet
-
IQVIA Vigilance Signal Detection
-
IQVIA Virtual Trials
-
IQVIAs Center for Health Data Semantics
-
IQVIAs Data Governance Solutions
-
IQVIAs Data Stewardship Services
-
IQVIAs Evidence-Driven Study Design
-
IQVIAs Experience and Expertise in Radiopharmaceutical Clinical Trials
-
IQVIAs Integrated IRT eCOA Platform
-
Is Your Organization IDMP Ready
-
Its time to move into One Home for Sites
-
KPI Library
-
Launch Lighthouse
-
Local Affiliate Product Services
-
Make faster business decisions with the E360 SaaS Platform
-
Making Fair Market Value a Reality
-
Market Access Insights
-
Market Access Solutions Fact Sheet
-
Marketing Agency Partner Program Fact Sheet
-
Master Data Management
-
Maximizing the Success of Your Brand
-
Measure New Market Opportunities in the Rapidly Evolving Oncology Landscape
-
Medical and Scientific Writing Solutions
-
Medical Device Registries Bridging the Gap Between Device Performance in Clinical Trials
-
Medical Science Liaisons
-
Meet Pre Launch Regulatory Requirements Across the Globe
-
National Anti-tumor Drug Surveillance System NATDSS Real World Data Fact Sheet
-
Navigating the challenges of combination products
-
Navigating The Use of Controlled Substances in Clinical Trials Using IRT
-
NLP Advancing Drug Safety Natural Language Processing
-
NLP Data Factory
-
NLP Human Assisted Review Tool for Healthcare
-
NLP Human Assisted Review Tool HART
-
NLP Insights Hub
-
NLP IQVIA Natural Language Processing NLP API Suite
-
NLP Labeling Intelligence Hub
-
NLP Platform
-
NLP Risk Adjustment Solution
-
NLP text analytics for Regulatory Affairs
-
NLP Unlock Patient Level Social Determinants Of Health
-
NLP Unlock the potential of field medical insights
-
NLP-driven Enterprise-wide Social Media Intelligence
-
Nordic Real World Data for Medical Devices
-
Obstructive Airway Diseases An Ongoing Worldwide Health Challenge Searching For New Answers
-
OHDSI OMOP Services
-
Ohdsi omop services common data standards for research outputs at your fingertips
-
OMOP Myth Busters
-
One Home for Sites Partnership Program Guide
-
OneKey Data Partner Program Fact Sheet
-
OneKey Healthcare Professional Reference Data Network
-
Optimize Your Content and Get the Most Out of Remote Healthcare Professional Engagement
-
Orchestrated Clinical Trials
-
Orchestrated Study Start Up with the IQVIA Investigator Site Portal
-
Orchestrating Efficiency
-
Perfecting The Movement
-
Pharma Sponsor Enlists Cenduit IRT to Rescue
-
Pipeline Architect
-
Poland Longitudinal Prescription Data
-
Privacy Consulting and Advisory Services
-
Real-World Evidence
-
Regulatory Affairs and Drug Development Solutions
-
Regulatory Lifecycle Management LCM Services
-
Responding to FDA Enforcement
-
Robust Audit Programs
-
Safety Suite Fact Sheet
-
Seize the Opportunity Identify and Acquire the Patients Your Brand is Missing
-
SmartSolve Audit Management
-
SmartSolve Automated Validation and Extended Validation Services
-
SmartSolve CAPA Management
-
SmartSolve Change Management
-
SmartSolve Complaint Management
-
SmartSolve Design Control
-
SmartSolve Document Management
-
SmartSolve eQMS Fact Sheet
-
Smartsolve eQMS for MedTech
-
SmartSolve Fundamentals for Pharma and MedTech
-
SmartSolve Inspection Management
-
SmartSolve Nonconformance Management
-
SmartSolve Out of Specification Management
-
Smartsolve Postmarket Surveillance
-
SmartSolve Quality Event Management
-
SmartSolve Quality Intelligence
-
SmartSolve RIM Submission Management
-
SmartSolve Risk Management
-
SmartSolve Supplier Management
-
SmartSolve Training Management
-
Social Media Intelligence
-
Strong Growth in Medicine Use in Developing Countries with Growth at Steady Rates
-
Successfully Conducting Your Digital Health Studies Using Real World Evidence
-
Take Your Insights to the Next Level With a Powerful Information Management Approach
-
Technology Partner Program Fact Sheet
-
The under-represented patient voice in research Making sure all voices are heard
-
Transforming Oncology Care
-
Translation Services
-
Treatment Satisfaction Questionnaire for Medication TSQM
-
Turn your gaps into advantages with IQVIA Functional Services
-
UK Dynamic Prescription Data DRx
-
UK EMR IQVIA Medical Research Data
-
UK Longitudinal Patient Data
-
Understanding Emerging Regulatory Requirements in Cell and Gene Therapy
-
Understanding Safety and Clinical Performance Regulations Medical Devices
-
Understanding the Regulatory Pathway for 510k Submissions
-
Understanding the Summary of Technical Documentation
-
Unlock Insights with Global In Vitro Diagnostic Market Data
-
Using IRT data to automate and optimize clinical supply
-
Venue Preparedness Study The New Normal of In-Person Promotional Programming
-
Verify HCP Identity with Confidence
-
Why IQVIA Participant Payments
-
Your Hematology Oncology CRO Partner to Navigate Complexity with Confidence
-
-
Infographics
-
A better approach to risk based monitoring
-
7 Things We Love About Risk Based Monitoring
-
A lifecycle approach to the use of RWE in HTA submissions
-
Accelerating therapeutic innovation for a healthier world
-
Access unparalleled insights into omnichannel engagement within the life sciences
-
Asian Market Trends in R and D 2024
-
Assessing the role of proposition and content for engagement specialists and HCPs
-
Biomarker Testing In Oncology
-
Biotech Firm Automates Grant-Funding Processes with Expanded Flexibility
-
Brave new world Evolving person based interactions in HCP engagement
-
Building on Contemporary Practice and Considerations for Real World Data Sources
-
Cell and Gene Therapy Support Across the Lifecycle
-
Change Management Lays the Groundwork for Smooth Overhaul of Compliance Platform
-
Consumer Health Virtual Trials Infographic
-
Demystifying the EU HTA Regulation
-
EU Oncology Biosimilars
-
EU regulation
-
Evaluate and Evolve your Hybrid Healthcare Professional Engagement Capabilities
-
Expected publications Oncology June 2022
-
FAQ Uncovering the Value of Agentic AI in Life Sciences
-
Future of Documents Infographic
-
H1 2022 vs H1 2021 Overview
-
Health Technology Assessments in 2021
-
Impact Assessment Workflow
-
Impact of additive PICOs in a European Joint Health Technology Assessment
-
Infographic value and access are you ready for the next era
-
IQVIA ChannelDynamics
-
IQVIA Commercial Intelligence AI Solutions Suite
-
IQVIA Continuous Glucose Monitoring
-
IQVIA Decentralized Trials
-
IQVIA™ Enterprise Information Management
-
IQVIA Field Force Agent
-
IQVIA Health Data Catalog
-
IQVIA Launch Excellence
-
IQVIA MDM Advance
-
IQVIA MIDAS Patient Redefining Pharmaceutical Strategy with Patient-Centric Intelligence
-
IQVIA OneKey Helps You Connect with HCPs
-
IQVIA Orchestrated Analytics with AI Assistant Infographic
-
IQVIA Patient Engagement and Support
-
IQVIA Patient Support Services
-
IQVIA Site Enablement Solutions
-
IQVIA Site Support Services
-
IQVIA TM Vigilance Platform See the Difference
-
IQVIA Vigilance Detect
-
IQVIA Vigilance Detect Self-Managed Solution
-
IQVIAs Regulatory Impact Assessment Workflow
-
Multichannel Pharmacovigilance How AI and NLP Support Drug Safety Monitoring
-
Orchestrating Efficiency infographic
-
People Now More Willing than Ever to Participate in Clinical Trials
-
Single Drug Assessment in 2022 vs 2021
-
Single Drug Assessments in Lung Cancer
-
SmartSolve eQMS Enhance quality and improve compliance throughout the product lifecycle
-
SmartSolve for Compliance
-
SmartSolve for Compliance AI Capabilities
-
IQVIA RIM Smart
-
Streamline MedTech Regulatory Operations with Smartsolve rim
-
The Global Use of Medicine and Trends in Asia Region
-
The Ovarian Cancer in Health Technology Assessments
-
Transforming Key Opinion Leader Identification
-
Understanding Key Factors Impacting Global Market Growth
-
Unlock the Future of Pharmaceutical Market Intelligence
-
Continuous Glucose Monitoring
-
Discover Opportunities Overlooked by CRM Alone
-
IQVIA Factoids
-
IQVIA Virtual Trials
-
Supporting the patient journey
-
Tailored solution for Rare Disease Studies
-
Transforming Patient Recruitment Through Patient and Site Engagement
-
Understanding what oncologists need for their patients and their clinics
-
Using Social Media to Recruit Potential Study Participants
-
-
Insight Brief
-
Accelerating CSR Timelines
-
Accelerating Data Lock to Clinical Study Report Completion
-
Accelerating Study Start-up with FSP
-
Achieving A Smooth Transition from Clinical Development to Commercialization
-
Activating Patient Participation in Clinical Trials
-
Advancing Digital Health Innovation Using Real-World Evidence
-
Alzheimers Disease Clinical Trials
-
Biocompatibility Trends and Best Practices for ISO 10993-1 Compliance
-
Bridging Borders
-
Chronic Cough in Interstitial Lung Disease
-
Clear Perspectives A Look Inside the IQVIA 2024 Transparency Aggregate Spend Survey
-
Clinical Development of Cell and Gene Therapy CAGT Products in Australia
-
Companion Diagnostics Regulatory Strategies
-
Constructing Defensible AI Platforms in Healthcare
-
Cutting Time Not Corners
-
Designing Effective Medical Device Clinical Studies
-
Differentiating Strategic Direction in a Competitive Obesity Market
-
Diversity Action Plans for Medical Device Clinical Trials
-
Driving Patient Centricity Through Remote Sample Collection
-
eConsent for Modern Clinical Trials
-
Embracing AI-Driven Technology to Augment Quality and Regulatory Activities
-
Everest Group Life Sciences Regulatory and Medical Affairs PEAK Matrix Report 2024
-
Exploring HIV in the PrEP Era Challenges and Opportunities
-
FDAs Draft Guidance on Dosage Optimization for Oncology Therapeutic Radiopharmaceuticals
-
FDAs Rare Disease Evidence Principles
-
Five Essential Aspects of Oncology Patient Support
-
Four Key Considerations for Patient Support in Obesity Care
-
From Digital Adoption to Patient Impact
-
From First Impressions to Final Reflections
-
From Framework to Field
-
Global Market Access A Regulatory Affairs Perspective
-
Implementation Science
-
Implementation science an essential partner in the real world
-
Implementation Science The Art of Intended Consequences
-
Innovative Approaches to Clinical Trial Financial Management
-
IQVIA MedTech physician surveys reveal how pulsed field ablation is scaling fast
-
IQVIA recognized as Leader by industry analysts Everest Group
-
Joint Scientific Consultations
-
Key Learnings from the MedTech Conference 2023
-
Leveraging commercial analytics managed services for sustainable market success
-
Leveraging commercial analytics managed services Spotlight on the hybrid approach
-
Leveraging Real World Evidence to Differentiate your IVD
-
Mapping Feasibility Criteria Across 46 Real-World Evidence Guidelines
-
Medical Device Clinical Evaluation Reports
-
MedTech Innovation Privacy Strategy for Big Data Excellence
-
No Easy Answers To The Silent Pandemic Taking A Fresh Look At Tackling Antimicrobial Resistance
-
Optimizing Doses for Combination Therapies in Oncology
-
Optimizing Remote Monitoring with FSP
-
Overcoming 7 Top Challenges of Commercial Leaders
-
Pathways to Overcome Challenges to CAR T-cell Therapy Readiness
-
Patient Organization Research Collaborations Interactions with Life Sciences Companies
-
Phased Progress Data Bridging as a Strategic Maturation Approach to MDM
-
Quality and Regulatory Professionals Question a Future with Cybersecurity Issues
-
Real World Evidence for Medical Device Regulatory Submissions
-
Shaping new paths for CNS
-
The Digital Transformation of Risk-Based Quality Management with a Clinical Monitoring Focus
-
The Evolution of FSP Not Just for Large Pharma
-
The first step on a long road ahead
-
Understanding In Vitro Diagnostic Risk Based Classification in EU and US
-
What is the Pharma Business Case for Digital Health
-
Why not Paper Answering Five Common eConsent Questions
-
-
Podcasts
-
AI for drug discovery an industry gamechanger
-
AI for R and D Episode 10 Agentic AI Shaping the Future of Clinical Research
-
AI for R and D Episode 7 AI for Successful Clinical Development
-
AI for R and D Episode 8 AI for Indication Selection
-
AI for R and D Episode 9 Agentic AI for Clinical Trials
-
AI for R and D Positively disrupting pharmaceutical R and D with AI ML
-
AI for RD Episode 5 Optimizing protocols by applying design analytics
-
Beyond Static Reports Dynamic Dashboards for Patient Level Insights
-
Clinical Trials Landscape in the UAE and Middle East
-
Consumer Health Edge Podcasts
-
Debunking value access and pricing myths Episode 1
-
Debunking value access pricing myths Episode 2 Pricing in Germany is always transparent
-
How AI and Real World Data are Reshaping Medical Affairs
-
Introduction to drug repurposing
-
IQVIA supports sites and participants through patient-centric trial experiences
-
Launch Excellence Podcast Series
-
Launch Excellence Podcast Series Episode 2 Addressing post Pandemic challenges
-
Launch Excellence Podcast Series Episode 3 Agile launch planning and performance management
-
Launch Excellence Podcast Series Episode 4 Rising Importance of Medical Affairs
-
Launch Excellence Podcast Series Episode 5
-
Launch Excellence Podcast Series Episode1 Preview of Launch Excellence VIII Report
-
Making Every Connection Count
-
New Ways to predict clinical trial success
-
Revolutionizing the clinical trial patient experience
-
The Benefits of Patient Centricity in Design
-
The Hidden Costs of the Vaccine Cold Chain
-
The Pharmaceutical Commerce Podcast RWD Fitness Steps for Pharma
-
-
Presentations
-
7 Market Access Trends for 2027
-
A Movement in Diabetes Using Time in Range
-
Design Control Quality Compliance for Medical Device Manufacturers
-
Innovations in RWI for APAC
-
IQVIA Research Forum 2022 Day 1
-
IQVIA Research Forum 2022 Day 2
-
IQVIA Research Forum 2022 Day 3
-
ISCB Conference 2019 Presentation on External Comparator Methods by Christen Gray
-
The Global Use of Medicines 2023
-
-
Publications
-
2024 Frost and Sullivan Global Customer Value Leadership Award Write-Up
-
A multi platform approach
-
A Patient Centric Approach to Digital Value Added Medicines Webinar Executive Summary
-
A Review of the Current Treatments and Pipeline Developments for HER2
-
Accelerating decision making and deployment with trusted Healthcare grade AI applications
-
acts 2017 31st Edition
-
acts 2018 32nd Edition
-
Acts 2019 33rd Edition Quality Assurance report of IQVIA
-
Acts 2020
-
Acts 2021
-
Acts 2022
-
Acts 2023
-
AI Machine Learning Publications Inventory
-
An Update on Treatment Options and Pipeline Developments for Alzheimers Disease
-
Analytics Powering the Enterprise
-
Beyond Weight Loss The Future of Obesity Treatment
-
Biopharma Companies Join Forces to Fight COVID19
-
Breakthrough Technologies Drive Upsurge in CNS Dealmaking
-
Building a stronger future in cancer care with a focus on earlier interventions and more
-
Cell and Gene R and D in Cancer Care Increasing Patient Access
-
ChannelDynamics Global Reference 2025
-
ChannelDynamics Global Reference 2025 December Report
-
Combinations take centre stage in PD1 PDL1 inhibitor clinical trials
-
Commercial Forecasting 2024 Survey Results
-
COVID 19 better therapeutics and vaccines on the horizon
-
COVID-19 Super-charging Drug Development in the Race for a Cure
-
Customer Expectations Have Changed Have You
-
Cutting the Financial and Time Costs of Regulatory Affairs with Automation
-
Deal Trends in Alzheimers Disease
-
Dermatology Clinical Trials RFP Planning Guide
-
Descriptive Analysis of the Use of Tyrosine Kinase Inhibitors in Chronic Myeloid Leukaemia
-
Enhancing Patient Centricity in Clinical Trials Through Connected Devices
-
Envisioning a bold new future of clinical development
-
Establishing the Self-Driving Clinical Trial
-
Everest Group AI-deas to Action
-
Everest Group Life Sciences AI and Analytics Services for Commercial PEAK Matrix Report 2025
-
Evolving the Understanding of the Natural History of Disease
-
From Insights to Impact IQVIA OneKey Global Marketing Services
-
Future Outlook for the Major Developed Pharmaceutical Markets and the Ongoing Impact of COVID 19
-
Gartner CRM Report Executive Brief
-
Get Ahead of Consumer Health Trends Across the Globe
-
HCP Engagement Strategies
-
How Automation AI and Data Integration are Transforming the Pharmaceutical Industry
-
How Machines Work in Healthcare
-
How to Devise a Cell Therapy Clinical Development Plan
-
IDC Link Building One Home for Sites How IQVIA Aims to Transform the Site Experience
-
IDC Marketplace Report names IQVIA as Leader in 2022 Vendor Assessment
-
IDC MarketScape
-
IDC MarketScape Worldwide Life Science R and D Decentralized Clinical Trial Technology Solutions
-
IDC MarketScape Worldwide Life Science R and D Pharmacovigilance Solutions 2022 Vendor Assessment
-
IDC MarketScape Worldwide Life Science Sales and Marketing
-
Improving Paediatric R and D Success
-
Independent Report on RWE Market from the Life Science Strategy Group
-
Intelligent Technology Impacting the Future of Clinical Research
-
Introducing the Human Data Scientist
-
Its all about Data fueling insights and powering intelligent actions
-
Launch Excellence
-
Lessons on Data Collection and Curation from the NFL Injury Surveillance Program
-
Modernizing Regulatory Evidence With Trials and Real World Studies
-
Modernizing the Natural History of Disease Research
-
Navigating an evolving landscape
-
New publication advancing COA linguistic validation with responsible AI
-
Orchestrating Outcomes in the Digital Age of Care
-
Paid Medias Essential Role in Your Omnichannel Strategy
-
Patient-centricity in the Biopharmaceutical Industry Are We Nearly There Yet
-
Peer to peer discussion Transforming the safety regulatory and quality experience
-
Retrospective Database Analysis of Liver
-
Sales from 2022 Launch Events Forecast to Outweigh Patent Expiry Losses across All Therapy Areas
-
Surprise pandemic lessons for pharma
-
TechIQ Europe Event Overview
-
Technology the Equalizer for Emerging Biopharma Patient Support Program
-
The Dynamics of Channel Deployment and HCP Engagement
-
The EU Clinical Trials Regulation Experiences from the first 18 months
-
The Global Use of Medicines 2022
-
The Global Use of Medicines 2024
-
The Impact of COVID-19 on Cancer Treatment EU5 Report
-
The Impact of COVID-19 on Cancer Treatment in France
-
The Impact of COVID-19 on Cancer Treatment in Germany
-
The Impact of COVID-19 on Cancer Treatment in Italy
-
The Impact of COVID-19 on Cancer Treatment in Japan
-
The Impact of COVID-19 on Cancer Treatment in Spain
-
The Impact of COVID-19 on Cancer Treatment in the UK
-
The Impact of COVID-19 on Cancer Treatment in the US
-
The Impact of COVID19 on Pharmaceutical Markets
-
The Impact of the COVID 19 Pandemic on Global Pharmaceutical Growth
-
The Impact of the COVID-19 Pandemic on Global Pharmaceutical Growth June 2020 update
-
The Outlook for the Latin American Pharmaceutical Market
-
The Patients WAIT Indicator 2025
-
The Role of AI in Signal Detection
-
Transforming a necessity into the ultimate partnership
-
Transforming the Customer engagement with best in class data and technology
-
Understand the Impact of COVID19 on Optimal Healthcare Professional Communication
-
Unlock the Keys to Effective Real World Data Usage
-
Unraveling the Impact of COVID-19 Across Regions
-
Using Patient Experience Data to Evaluate Medical Interventions
-
Using Patient Experience Data to Evaluate Medical Interventions Chapter 1
-
Using Patient Experience Data to Evaluate Medical Interventions Chapter 4
-
Using Patient Experience Data to Evaluate Medical Interventions Chapter 7
-
Using Patient Experience Data to Evaluate Medical Interventions full book
-
When Context is Hard to Come By
-
OneKey in Action
-
Pricing and Market Access Outlook 2017
-
Pricing and Market Access Outlook 2018
-
The Future of Customer Experience CX is Orchestrated Engagement
-
-
Scientific Posters
-
A Comparison in Non-Small Cell Lung Cancer
-
ADPD 2026 Poster
-
Evaluating consistencies in measuring patients HRQoL
-
Identifying Undiagnosed Patients with Hepatitis C
-
Impact of tumour genomic characteristics on healthcare resource utilisation
-
Internal Validation of Type 2 Diabetes and Cardiovascular Events Incidence in the CODM
-
IQVIA Publications in ASCO 2021
-
IQVIA Publications in ASCO20 Virtual Scientific Program
-
ISOQOL 2025 Poster A Comprehensive Literature Review of Definitions and Methods
-
ISOQOL 2025 Poster Evaluating Agreement Metrics Used in Analytical Validation
-
ISOQOL 2025 Poster Intraclass Correlation Coefficients
-
ISOQOL 2025 Poster Migration Inconsistencies
-
ISOQOL 2025 Poster Scientific Best Practices in Electronic Clinical Outcome Assessments
-
ISOQOL 2025 Poster Subgroup or Principal Stratum Analysis
-
ISOQOL 2025 Poster Using a Multiple-Case Study Design
-
ISPOR EU Poster A collection of essays on patient centricity in intervention development
-
ISPOR EU Poster Evaluating Migration Errors in COA Development and Validation
-
ISPOR EU Poster Looking Back to Go Forward Reintegrating Scientific Considerations
-
Leveling up RWE adoption by US payers
-
Outlook for medicine use and spending through 2027 Impact on the pharmacy sector
-
Panel-based tumor mutational analysis matched tumor plasma specimens Illuminas TruSight Oncology
-
Preparing for Climate Change The Essential Role of Pharmacy in Addressing the Next Global Crisis
-
Pricing and Market Access Posters
-
Trends in Targeted Cancer Therapies Becoming Right Comparators for Payers
-
What counts as a cancer diagnosis in real world data
-
-
Videos
-
2021 NFL Preseason Injury Prevention Player Health Safety
-
2025 Indicators of Progress for the Life Sciences Sector
-
9 Key Insights for Life Sciences Commercial Models
-
A Conversation about Clinical Technologies
-
A glimpse at HCPO Engagement Management
-
Accelerate Insights and Collaboration in Clinical Development
-
Adopting Virtual Approaches in Oncology Trials Webinar
-
Allergy Plus increases user engagement with new provider search module
-
An ideal partnership IQVIA and Incyte paving the way to a digital training program
-
Ark Patent Intelligence Worldwide Pharmaceutical Patent Information
-
Best Practices for Implementing a New Payments Solution
-
Boost efficiency of patient identification for clinical real world research
-
Boost Patient Engagement with Mobile and Web Apps with the IQVIA HealthCare Locator SDK
-
Built By Trust Changing Customer Needs
-
Can technology change behavior Can decision intelligence change the way we experience the world
-
Client Interview Collaboration to Build a Strong Foundation
-
Clinical Data Analytics Solutions Explainer Video
-
Clinical Functional Service Provider
-
Clinical Trial Analytics Services Overview 30 cutdown Video
-
Clinical Trial Analytics Services Overview Video
-
Clinical Trial Management System
-
Commercial Analytics Video Long 09 2019
-
Commercial Forecasting on a Glocal Scale
-
Connect Multiple Dots with Orchestrated Customer Engagement
-
Connecting with Rare Diseases
-
Consumer Healthcare Virtual Real World Research Webinar
-
COVID19 Healthcare App Challenge Winners Announcement
-
COVID-19 The Catalyst for Change in Global Market Access
-
CRA Central
-
Customer engagement excellence
-
Customer Perspective IQVIA RIM Smart
-
Data Management Data Flow Ecosystem
-
Data Strategy in Clinical Trials Unlocking Patient Centric Insights
-
Data-driven Trial Execution
-
Delivering results and exceeding expectations IQVIA supports first EEFAM Congress
-
Designing Oncology Clinical Development Programs Video
-
Destination Kochi Join IQVIA
-
Developers and AI the future of healthcare
-
Digital Health Trends 2025
-
Digital therapeutics in the NHS Summit
-
Direct to patient studies Health Research Space
-
Drug Shortages in the US 2023
-
E360
-
Engaging Virtual Meetings Experiences
-
Enhance UX Content Targeting and Compliance for HCP Apps with the IQVIA HealthCare Authenticator SDK
-
Environment Social and Governance video
-
European Pharma Trends Beyond the Pandemic
-
Evolving Patient Support to Address Patients Needs in Todays COVID19 Landscape
-
Expanding Options for Emerging Biopharma in the US A conversation with Meg Hooton IQVIA Biotech
-
Expertise Across Rare Disease Indications
-
From Molecule to Market: Deliver Credible Results with Confidence
-
Fusion 2022 Event Overview
-
Global Oncology Trends 2025
-
Global R and DS Trends 2026
-
Global Trends in R and D 2023
-
Global Trends in RD 2025 Video brief
-
GrantPlan Video
-
HCP Engagement in the New Environment
-
Hematologic cancer opportunities for Patient Equality
-
How can stakeholders ensure Digital Health reaches its full potential
-
How Critical is the Rep to Orchestration
-
How EY and a Top 10 Pharma Tackled the Challenges of Site Payments
-
How IQVIA Advanced AI Helps Doctors Treat Patients
-
How to Build a Compelling Business Case to Change Payment Solutions
-
Human Data Science in Action
-
Hyper Personalize Your HCP Engagement in Real Time with OneKey
-
Incentive 360
-
Innovative real world evidence approaches
-
Integrated Data Platform demo video
-
Introducing an IQVIA service for Chain Pharmacy Organizations
-
Introduction to Market Access Insights
-
Introduction to the IQVIA COVID19 Active Cases Curve Simulator
-
IQVIA Advanced Commercial Analytics Solutions powered by AI
-
IQVIA Analytics Link Ecosystem
-
IQVIA and EBP The Credibility of Experience and the Power of Innovation
-
IQVIA Asset Maximizer
-
IQVIA Chemical Intelligence
-
IQVIA Clinical Trial Educators
-
IQVIA Clinical Trial Financial Suite
-
IQVIA Commercial Compliance
-
IQVIA Complete Consent
-
IQVIA Connected Intelligence Make Better Decisions
-
IQVIA Consumer Health Shape a Healthier World
-
IQVIA Contract Sales and Medical Solutions
-
IQVIA CORE Enabled Clinical Development
-
IQVIA CORE Powered Clinical Development
-
IQVIA CORE Powered Clinical Development Video Event version no audio
-
IQVIA Customers challenging the status quo
-
IQVIA Decentralized Trials
-
IQVIA Design Analytics Overview Video
-
IQVIA eTMF Demo
-
IQVIA Field Force Agent
-
IQVIA Field Force Agent Demo Integrated with Salesforce Agentforce
-
IQVIA FlexView v22
-
IQVIA Forecast Link
-
IQVIA Global Market Insights Agent Video
-
IQVIA Grant and Funding Management
-
IQVIA HealthCare Locator SDK
-
IQVIA Institute Year in Review 2024
-
IQVIA Institute Year-In-Review 2025
-
IQVIA Integrated Compliance solutions
-
IQVIA Investigator Site Portal
-
IQVIA Medical Information
-
IQVIA Medical Information Short
-
IQVIA MedTech Recall and Field Action Program Video
-
IQVIA MIDAS Patient
-
IQVIA Next Best Marketing Ops
-
IQVIA Next Best Sales Op
-
IQVIA NLP APIs
-
IQVIA NLP Data Factory
-
IQVIA partnership elevates EEFAM annual meeting
-
IQVIA Patient Portal
-
IQVIA Pipeline Architect Data driven Clinical Development Plans
-
IQVIA Primary Intelligence Solutions Primary market research by real world data advanced analytics
-
IQVIA PSCS Site Support Services
-
IQVIA Remittance Advisor
-
IQVIA RIM Smart
-
IQVIA SMART BI Technology Upgrade
-
IQVIA SmartSolve Design Control
-
IQVIA SmartSolve Risk Management Overview
-
IQVIA Technologies Global Partnership Awards Program
-
IQVIA Technologies Risk-Based Monitoring Video
-
IQVIA Technologies What If
-
IQVIA Technology Solutions Investor Day 2019
-
IQVIA Transparency Reporting
-
IQVIA Vigilance Analytics
-
IQVIA Vigilance Detect
-
IQVIA Vigilance Detect or Collect Demo Video
-
IQVIA Vigilance Intake
-
IQVIA Vigilance Platform
-
Is Your Launch Preparation COVID 19 proof
-
Learning Management Demo Video
-
Leveling up supply chain management to ensure accountability sustainability IP optimization
-
Make your events exciting with IQVIA Virtual Meeting Services
-
Making a learning healthcare system a reality with connected intelligence
-
Making sense of data Focusing on solutions over inputs to maximize value
-
MedTech Clinical Solutions Across the Product Lifecycle
-
MedTech Concept to Market Solutions
-
Mitigating risk and complexity in Cell and Gene Therapy trials with IRT
-
Natural Language Processing NLP Insights Hub
-
Oncology Dynamics
-
On-demand webinar Solutions for Evidence Optimization and Dissemination
-
One Home for Sites Video
-
OneKey the foundation that matters
-
Optimize data to accelerate time to insights
-
Orchestrated Analytics
-
Orchestrated Analytics with AI Assistant
-
Orchestrated Clinical Trials Overview
-
Orchestrating Efficiency
-
Overwhelming Challenges in Healthcare
-
Partner Marketing Annual Awards Video
-
Pathway to Success in Cancer Treatment Hybrid Event
-
Pharmacy Intelligence Chain Service Teaser Video
-
Pharmacy Intelligence Store Manager educational promo video
-
Pharmacy Intelligence Store Manager teaser video
-
Pharmas Dilemma Drive growth in an era of multi model disruption
-
Physician Perspectives How do pharmaceutical companies communicate with you
-
Post Authorization Safety Studies with Nancy Dreyer
-
Reach the hidden insights for cutting edge go to market strategies
-
Real World Evidence to Support Biotech Companies from Milestone to Milestone
-
Real-World Data
-
Reducing the Impact of Macroeconomic Pressure on Trial Supply
-
Research Brief Global Medicine Use Trends 2026
-
Risk Based Monitoring
-
Safety Notifications Demo
-
Secondary Data First
-
Stakeholder Engagement with Human Data Science
-
Start small dream big succeed now
-
State of Radioligand Therapy Readiness Europe
-
Streaming analytics and the promise of better health
-
Sub-population Optimization and Modeling Solutions SOMS
-
Supercharge your commercial strategy with AI
-
The changing regulatory landscape for using Real World Evidence
-
The Future of Digital Biomarkers
-
The Generics Lifecycle Be Ahead of the Competition in Finding the Right Opportunities
-
The Global Use of Medicines 2023
-
The Global Use of Medicines Outlook Through 2029
-
The growing regulatory use of real world evidence
-
The IQVIA Institute for Human Data Science
-
The Power of Digital Biomarkers
-
The Power of Human Data Science
-
The Principles of Human Data Science
-
The Principles of Real World Evidence
-
The ROI of IQVIA Site Payments
-
The value of AI in clinical practice and life science organizations role in this multi stakeholder
-
Transform HCP Message Recall Analysis with AI-Driven Insights
-
Unlocking Biosimilar Potential
-
Unlocking Biosimilar Potential Learnings from an Osteoporosis Case Study of Complex Patient Pathways
-
Using data to customize prescriber interactions for better resonance and commercial success
-
Using open source to accelerate patient cohorting
-
Video Research Brief Understanding the Use of Medicines in the US 2025
-
Vigilance Detect Extract Turning Patient Support Data into Actionable Safety Intelligence
-
We are IQVIA
-
Webinar Optimize Next Best Action Tools To Deliver Value based Engagement
-
Webinar The COVID-19 Pandemic in the EU4 UK A Year in Review
-
Webinar The Ongoing Impact of COVID19 on New Product Launches and Cancer Care
-
What are Digital Biomarkers
-
What does the voice of the customer tell life science companies
-
What is the Significance of the Platform of Platforms Strategy
-
Where do we see Digital Health emerging in the context of Human Data Science
-
Where is there evidence that Digital Health is adding value to healthcare systems
-
Which Payments Model is Right for your Organization
-
-
White Papers
-
2017 US Trends in Aggregate Spend Disclosure and Transparency
-
2019 US Trends in Aggregate Spend Disclosure and Transparency
-
2020 U S TRENDS IN TRANSPARENCY REPORTING
-
2022 Speaker Bureau Benchmarks Report
-
2023 Speaker Bureau Benchmarks Report
-
2024 Safety and Regulatory Compliance Trends and Predictions for Pharma and Biotech
-
2025 Pharma Deals Annual Review
-
2025 Safety and Regulatory Compliance Trends and Predictions for Pharma and Biotech
-
21st Century Regulatory Publishing
-
A Big Deal Strategic Rejuvenation for Post Pandemic Realities
-
A Blueprint for Optimizing RIM System Deployment Notice
-
A Call to Action Alzheimers Disease on the Threshold of Change
-
A Look into the Epidemics Impact on Korea Healthcare
-
A Network Model for Early Clinical Development
-
A new AI augmented horizon for safety and pharmacovigilance
-
A New Dawn At the Cusp of the CNS Decade
-
A New Look at RD Productivity How small changes key levers can dramatically impact cost per output
-
A Perspective on How 2022 Began Defining the New Normal
-
A Practical Approach and Lessons Learned from Aligning Regulatory Master and Reference Data
-
A renaissance for cardiometabolic innovation
-
A time for critical change
-
Accelerate Global Market Access with Confidence
-
Accelerating Biosimilar Drug Development Using Bayesian Methods
-
Accelerating Consumer Health Innovation
-
Accelerating market access for a maturing medtech industry in APAC
-
Accelerating study start up through an eCOA library
-
Achieving a Win Win
-
Achieving new heights in trial management with co-created FSP solutions
-
Achieving Oncology Launch Excellence
-
ACTS 2016
-
Acute Myeloid Leukemia
-
Ada
-
Adapting Enterprise Information Management Strategies in the COVID Endemic World of Life Sciences
-
Addressing Unmet Healthcare Needs
-
Adopt Technology Solutions to Innovate and Streamline Your Regulatory Services
-
Advanced HCP Targeting
-
Advances Towards Automating Safety Data Entry
-
Advancing Health System Sustainability
-
Advancing Scientific Exchange
-
Agentic AI in Life Sciences MDM
-
Agile Stockpiles
-
AI Agents for Medical Information
-
AI in Change Management
-
AI In Clinical Development
-
AI In Cloud 30 and Roadmap For Adoption
-
AI in Life Science Quality Management and Regulatory Affairs
-
AI in Life Sciences Commercialization
-
AI-Driven Remote Patient Monitoring Devices
-
Algorithmic Forecasting for the Life Sciences Industry
-
An Agentic AI-Powered Consumer Health Revolution
-
Antibody Drug Conjugates in Cancer Drug Development
-
Antibody Drug Conjugates in Cancer Therapy
-
APAC perspective on Fostering Success in CNS Innovation
-
Apollo
-
Applied Adaptive Design Using Subgroup Identification and Machine Learning
-
Applying AI in Todays Reality of QARA Processes
-
Applying Artificial Intelligence and Machine Learning to drive earlier diagnosis
-
Artificial Intelligence and Machine Learning with Advanced Analytics
-
Artificial Intelligence in Drug Development
-
Assessing person centered therapeutic innovations
-
Attracting Investment in Clinical Development
-
Beneath the Surface Unravelling the True Value of Generic Medicines
-
Best Practices for RWD RWE Used in Regulatory Filings
-
Best Practices with CEVA
-
Beyond Automation How Strategic LQPPV Outsourcing Future proofs PV Compliance in the AI Era
-
Beyond Buzzwords
-
Beyond Integration Flexible Orchestration of IRT and eCOA Solutions
-
Beyond Transparency AI Compliance and Strategic Insights
-
Bigger on the Inside The Expanding World of Microbiome Therapeutics
-
Biologics The Key to Next Generation Dermatology RD
-
Biosimilars for Retinal Vascular Diseases
-
Biotechnology And Pharmaceutical Companies Are Embracing Regulatory Technology Outsourcing
-
Breaking New Ground Advancing Cancer Care with Novel Therapeutic Modalities
-
Breaking New Ground with Digital Biomarkers
-
Bridging the Language Gap
-
Build a More Robust Model to Support Local Pharmacovigilance and Medical Information Activity
-
Build Predictability Into the Unpredictable
-
Building Trust Safety and Value in Regulated Healthcare Systems
-
Capturing the Attention of Investors
-
Capturing value at scale The $4 billion RWE imperative
-
Cell and Gene Therapy Logistics Management A holistic approach
-
Cell and Gene Therapy Commercialization
-
Cell and Gene Therapy Logistics
-
Change is Coming
-
Changing the Game
-
Channel Preference Versus Promotional Reality
-
China Embraces Decentralized Clinical Trial Solutions
-
Chronic disease management Diabetes
-
Claiming your share of the digital MedTech market
-
Clinical Data Flow The Foundation of a Biostatistics Ecosystem Within a Data Universe
-
Clinical Decision-Making in the Era of Generative AI
-
Clinical Trial Considerations in Cerebral Protection for TAVR Patients
-
Clinical Trial Continuity During COVID-19
-
Clinical Trial Participant Payments Navigating Global Complexity and Modern Studies
-
Clinical Trials Moving from Site to Home Lesson learned from Digital Health Technologies
-
CLL Treatment Slow But Sure Progress
-
Co-creating a New Health Ecosystem
-
Combination Therapy Dose Optimization in Oncology Trials
-
Commercial forecasting in a time of crisis
-
Commercialization Accelerator for Emerging Companies
-
Communicating the Value of Independent Medical Education to Key Stakeholders
-
Complex Generics Charting a new path
-
CONAN Complementary Pattern Augmentation for Rare Disease Detection
-
Concentration-QT Modeling
-
Conducting Effective Post Market Safety Studies for Medical Devices
-
Connected Data Flow and Standards A Data Management Approach
-
Connected Devices Better Data
-
Connecting Digital Solutions to Orchestrate Customer Engagement in a Rapidly Changing World
-
Consumer Health Digestives Category QuickView
-
Consumer Health Innovation For The Future
-
Control Your Data Flow Control Your Trial
-
Convergence of Pharma MedTech and HealthTech in Delivering Personalized Medicine
-
Corporate Integrity Agreements
-
COVID 19 and the New Normal for the MedTech Commercial Model
-
COVID 19 Rapid response and financial impact for the IVD industry
-
COVID Driven Surge Pushes Medical Information Teams to Virtualize
-
COVID19 Pushes Regulatory to the Cloud and Outsourcing
-
COVID-19 Pushes Regulatory Toward the Cloud Outsourcing
-
COVID-19 Vaccine Post-Market Studies
-
Creating a Motivating Engagement Ecosystem
-
Data Digitization and Disruption
-
DCTs Deliver Big ROI
-
Deal Trend in Immuno oncology
-
Deal Trends in Gene Therapy
-
Decentralized Oncology Trials How digital health and COVID-19 are transforming cancer research
-
Decisions in Cell and Gene Therapy Development
-
Defining and Collecting Patient-Reported Treatment Tolerability to Inform Drug Development
-
Delivering Next Generation Commercial Capabilities Within The Pharmaceutical Industry
-
Delivering value and efficiencies beyond traditional FSP resourcing
-
Demanding More from AI Governance in Drug Safety
-
Demystifying AI ML for Data Management
-
Deploying digital technology in virtual trials
-
Design For Registration Principles Of A Global Approach Executive Summary
-
Designing for Diversity
-
Digital Future for Value Added Medicines
-
Digital Health in the Real World
-
Digital Imperative Launch Excellence in an Omnichannel World
-
Digital Transformation A New Era for Clinical Trials
-
Digital Transformation for Consumer Health
-
Digital Transformation Success
-
Digital Twins in Healthcare
-
Distinguish Yourself With Risk Based Supplier Inspections
-
Dose Finding in Early Clinical Trials with IQVIA Trial Designer
-
Driving Decision Making Using Adaptive Trials
-
Driving Growth with Omnichannel HCP Activation
-
Driving Launch Success
-
Driving Transformation in Quality Regulatory and Compliance Environments
-
Drug Safety in Pregnancy Methods and Challenges
-
Drugs vs devices
-
DTx East 2022 Conference Recap
-
Dynamic Data Feeding Flexible Workflows
-
Dynamics of Self-Care Medical Devices in Europe
-
eCOA Implementation Guide
-
eCOA Licensing Guide
-
eConsent for Complex Clinical Trials
-
eCTD 4 0 Implementation Including Understanding of Regional Differences and Benefits
-
eCTD 4 Implementation Including Understanding of Regional Differences and Benefits
-
Editing the DNA of Pharma Go To Market Models
-
Effective Data Strategies for Life Sciences
-
Effective Strategies for Post-approval Lifecycle Management
-
Efficient Real World Evidence Generation with Enriched Methods
-
Elective surgeries in US and EU amid COVID19
-
electronic clinical outcome assessment eCOA Technology Guide
-
Elevating the Authentic Voice of Patient Advocacy
-
Embracing AI in Quality Operations Insight Brief
-
Embracing AI-Driven Technology to Augment Quality and Regulatory Activities
-
Embracing Change and Dealing With It
-
Emerging from the Shadows A New Era for NASH
-
Emerging Market Expansion Strategies
-
Empowering Clinical Research Sites and Sponsors in the Patient-centric Era
-
Empowering Mid-size Pharma Companies
-
Empowering Patient Driven Research to Improve Patient Outcomes
-
Empowering the Patients Voice
-
Engage with Confidence Managing Online Adverse Event Reporting
-
Enhance your Global MDM Strategy
-
Enhancing Commercial Insight in Healthcare Through Advanced Analytics
-
Enhancing Patient Safety A Paradigm Shift Through Early AI Adoption in Pharmacovigilance Workflows
-
Enhancing Primary Market Research through Artificial Intelligence
-
Enhancing the Efficiency of Pharmaceutical R and D
-
Ensure your data is well positioned to be the perfect foundation for strategic decision making
-
e-Pharmacy and the New Consumer Whitepaper
-
E-pharmacy Landscape in Hungary
-
eTMF and the eClinical Universe
-
eTMF as a Factory
-
EU HTA in action
-
European Health Data Space EHDS
-
Everest Group Life Sciences Next-generation Customer Engagement Platforms
-
Evolution to Cloud 30 and Roadmap for Adoption
-
Evolving Landscape of Immuno-Oncology The India Perspective
-
Evolving the Biomedical Innovation System
-
Evolving to thrive Europes mid sized pharma face the 2020s
-
Excellence in Immuno Oncology Clinical Trials
-
Expanding Clinical Trials into New Territories
-
FDAs Questions and Answers on 21 CFR Part 11 for Clinical Investigations
-
Finding All the Needles in the Haystack Technology Enabled Patient Identification
-
Finding the best entry strategies into new markets
-
Firestorm to Burnout The Impact of the Pandemic on Healthcare Professionals
-
Forget Almost Everything You Know About Pharmacovigilance
-
From Data Management to Data Science
-
From Enhanced Workflows To Advanced Analytics
-
From Orphan to Opportunity Mastering Rare Disease Launch Excellence
-
From Paper to Platform
-
From Regulated Prices to Prices Set in Tenders
-
From Surviving to Thriving Changing the Paradigm of HCP Interactions
-
Fully Automated Safety
-
Future Proofing Long Term Follow Up in Cell and Gene Therapy
-
Future Proofing QARA AI Practices
-
Futureproofing Post-Approval Compliance by Integrating LQPPV
-
Futureproofing Your Quality Operations Through Digital Transformation Executive Summary
-
Generative AI The Future of Pharmacovigilance
-
Getting Ahead of Consumer Health OTC Trends in the Middle East 2022
-
Global Approaches to Drug Development
-
Global consumer health trends 2023
-
Global Consumer Health Trends 2023 Consumer Mindset in Uncertain Times
-
Global Consumer Health Trends 2023 Digital Innovation
-
Global Consumer Health Trends 2023 Impact of Pricing
-
Global Consumer Health Trends 2023 Trends in e Commerce
-
Global Outlook on the In Vitro Diagnostics Industry
-
Going Global with eConsent
-
Grants Program Management ebook
-
Growth through Commercial
-
Half-Year Review of 2023
-
Harnessing AI Beyond Chatbots to Innovate Medical Information Offerings
-
Harnessing the Multitudes Charting the Future of Microbiome Therapeutics
-
Harnessing the Power of Artificial Intelligence in Medical Affairs
-
Harnessing the Power of Patient Organisations A Case Study of PO-Driven Drug Development
-
Harnessing Timely Patient Voice
-
HCP Channel Preference in an Increasingly Complex Promotional Landscape
-
HCP Promotional Engagement Benchmarks
-
HCP Promotional Engagement Benchmarks Report
-
HINT Hierarchical Interaction Network for Clinical Trial Outcome Prediction Insight Brief
-
Hospital Capacity Management Making Best Use of Available Resources
-
How Big Is the Opportunity Navigating market sizing in devices and diagnostics
-
How Clinical Trial Design Impacts Enrollment of Diverse Populations
-
How clinical trial results impact biopharma valuations
-
How Early-Stage Planning Strategies Are Optimizing Drug Development
-
How Healthcare Structures Can Drive or Inhibit the Adoption of New Medtech
-
How Real World Patient Generated Health Data is Shaping the Medtech Landscape
-
How Switzerland is Contributing to the Commercial Success of Biotech Companies Worldwide
-
How to Build Your Quality Nirvana
-
How to create a robust postmarket surveillance program that cuts costs while enhancing performance
-
How to Ensure Local level Pharmacovigilance Compliance and Efficiency
-
How to future proof your pharmacovigilance delivery model
-
How to Successfully Use ClinROs in CNS Clinical Research
-
How To Unlock the Potential of Hybrid Healthcare Professional Engagement With Content That Exceeds
-
Humans and Artificial Intelligence Unite
-
Identifying MedTechs Hidden Complaints and Adverse Events
-
Impact Population Lifestyle on Rate of Medical Technology Adoption
-
Improving Clinical Development in EBP Settings
-
In pursuit of Medical Launch Excellence
-
In the Eye of the Storm PD L 1 Inhibitors Weathering Turbulence
-
In the thick of it Medical Affairs strategic partner to other functions
-
Inclusion of Obese Individuals in Early Phase Healthy Volunteer Trials
-
Increase Efficiency and Reduce Risk with a Molecule-to-Market Action Plan
-
Industria farmaceutica
-
Industry Support for Patient Advocacy Organizations Do You Have the Right Tools
-
Inflammatory Bowel Disease Therapeutics on the Rise
-
Information Management The Key to Commercial Success in Pharma
-
Innovating with Confidence and Focus
-
Innovation in Primary Care is Alive and Well
-
Insights into MASH Clinical Research
-
Integrated Asset Development for Optimizing Value and Outcomes
-
Integrated Desk Research
-
IQVIA Connected Devices powers trials with better data
-
IQVIA CORE enabled Clinical Development at the Heart of Innovation and Launch Excellence
-
IQVIA eTMF Response to EMA Reflection Paper on GCP Compliance
-
IQVIA eTMF Response to MHRA Good Clinical Practices Guide
-
IQVIA Labeling Compliance Solutions
-
IQVIA Pharma Deals Half year review of 2022
-
IQVIA Pharma Deals Half-year Review of 2024
-
IQVIA Pharma Deals Review of 2021
-
IQVIA Pharma Deals Review of 2022
-
IQVIA Pharma Deals Review of 2023
-
IQVIA Quarterly Pharmaceutical Market Outlook Report
-
IQVIA Receives the 2023 Frost and Sullivan Enabling Technology Leadership Award
-
IQVIA SmartSolve Position Regarding 21 CFR Part 11 Requirements
-
IQVIA SmartSolves Position Regarding the Requirements of EU Volume 4 GMP Annex 11
-
IQVIA Social Intelligence Report
-
IQVIA Trial Designer
-
IQVIA Vigilance Detect Insight Brief
-
Is Your Regulatory Information Management Process Putting Your Company at Risk
-
ISO 13485 Standard and SmartSolve
-
Its Time to Play
-
Journey into the Whirlwind
-
Keeping Pace with Real World Evidence Evolving Software Regulations
-
Key Elements of Patient Centered Research
-
Launch Excellence Escaping the Complexity Trap
-
Leveraging Artificial Intelligence and Machine Learning to Drive Commercial Success
-
Leveraging French Public Transparency Data for Strategic Insights
-
Leveraging insights across the patient journey to develop hyper targeted campaigns
-
Leveraging market data to drive commercial MedTech performance
-
Leveraging Real World Evidence to Support Oncology Targeted Therapies
-
Leveraging Real-World Data to Estimate Race and Ethnicity Representation in Clinical Trial Design
-
Leveraging Regulatory Expertise to Optimize your Design Investment
-
Lexi
-
Living with a long-term condition the adolescent experience
-
Looking at the current and future landscape in respiratory connected devices
-
Loss of Exclusivity Considerations for a defense strategy in India
-
Machine Learning Applications for Therapeutic Tasks with Genomic Data
-
Making Intelligent Connections Possible
-
Making real-world evidence meaningful and actionable
-
Making the Move Bringing Cell and Gene Therapy Development Programs to the US
-
Managing the Unexpected
-
Master Data Management
-
Maximize Your Engagement Strategies With Artificial Intelligence and Machine Learning
-
Maximizing post-market surveillance with real world data
-
Maximizing the Value of Medicines to Patients
-
Measuring the Impact of Scientific Communications to Drive Launch Excellence
-
Medical Affairs Next Frontier Unlocking Omnichannel Engagement
-
Medical Device Development in Asia Pacific
-
Medical Information Goes Digital
-
Medical Information in a Post COVID World
-
Medical Information Teams Embrace Artificial Intelligence
-
Medical Launch Readiness
-
MedTech Asia Pacific Winning with innovation
-
Meet the Challenges of Regulatory Information Management
-
Mergers and Acquisitions How to manage regulatory risk and avoid issues
-
Minimal Residual Disease in Multiple Myeloma
-
Mitigating Drug Shortages
-
Mitigating Risk and Disruption in the MedTech Sector
-
Mitigating Trial Risk in ALS Clinical Development
-
Modernizing Obesity Trials
-
Natural History Studies for Rare Diseases
-
Navigating Chinas MedTech Market
-
Navigating COVID 19 Impact
-
Navigating IDMP Through the Extended EudraVigilance Medicinal Product Dictionary
-
Navigating the Complex Realities of Biomarker Testing in Oncology
-
Navigating the Complexities of Clinical Trial Site Payments Forecasting
-
Navigating the European Markets Regulatory Complexities
-
NEMEA The Essential European Revolution
-
New Challenges in Pharmacovigilance
-
New Perspectives on Consumer Health in Pharmerging Markets
-
Next generation Forecasting
-
Next Generation Target Product Profiles
-
nlp from data to evidence how nlp advances precision medicine and population health
-
NLP Mining Unstructured Patient Data For Successful Population Health Management
-
NLP Natural Language Processing For Payers And Health Plans
-
NLP Navigating new large language models in healthcare
-
No More Surprises Understanding Predictors of Launch Success
-
Not All Fixed Dose Combinations are Equal
-
Nutrition as the Keystone for Obesity Management Medication
-
Obesity Treatment Rates Increase as GLP 1 Inhibitors Prosper
-
Objectively tracking lesions in dermatology clinical trials
-
On the Brink of Change How Academic Data and Machine Learning Can Revolutionize Alzheimers Drug Deve
-
Oncology Landscape More Demand Demands More
-
Oncology Phase 1 Trials
-
Opiate of the Masses
-
Opportunities in Evidence Generation for Tumor agnostic
-
Opportunities in Moving Care Nearer the Patient
-
Optimizing Early Phase Clinical Trials
-
Optimizing End-To-End Safety In Clinical Development With Combined PV Solutions
-
Optimizing Generative AI in Clinical Operations through Focus Restraint and Maximized Validation
-
Optimizing Regulatory Lifecycle Management
-
Organizing for Success
-
Orphan Drugs An Update on Key Selected Pipeline Developments for Rare Diseases
-
Orphan Medicines Launch Excellence
-
Our Perspectives on the US FDA Patient-Focused Drug Development PFDD Guidance 1 and 2
-
Our Perspectives on the US FDA Patient-Focused Drug Development PFDD Guidance 3 and 4
-
Outperform by 30 with Next Best
-
Outsourcing Clinical Trials for Medical Device Companies
-
Overcoming Pharmas Launch Performance Problem
-
Overview of the NASH Development Landscape Opportunities and Lessons Learned
-
Paradigm Shifts in Early Phase Non-Oncology Studies in Healthy Volunteers and Patients
-
Partnering Solutions for Emerging Biopharma
-
Patient Centricity by Design
-
Patient Defined Recruitment The Movement Advanced by the Pandemic
-
Patient Voice Impacts Treatment Experience
-
Paving the Path in Haematological Cancers
-
Pediatric Oncology Trials Changes on the Horizon
-
Perfecting the Movement
-
Perspectives on Infant Nutrition and Health Claims
-
Perspectives on the Availability of Innovative Medicines
-
Pharma Deals Half Year Review of 2025
-
Pharmacies at a crossroad
-
Pharmacovigilance Automation Has Arrived
-
Pharmacy Compliance Report
-
Pharmas Frozen Assets
-
Pharmas Future Customer Facing Team
-
Placebo response in Psychiatry Trials Truth or Myth
-
Placing The Right Bets Defining Tailored Investment Strategies for Pharma Launch
-
Planning to Engage A Holistic Approach to Patient Inclusion
-
Positioning QARA as a Market Access Function in Globalization
-
Post COVID-19 MedTech Industry View on Surgical Procedure Backlog
-
Post launch Stage Projects Patient centricity Chinese Pharmaceutical Industry Pfizer China
-
Power your clinical trials with better solutions
-
Powering Launch Excellence with Patient Engagement and Support PES Programmes
-
Pragmatic Application of Healthcare AI Governance
-
Predictive Analytics in Oncology
-
Procurement Best Practices for Sourcing Language Solutions in Pharma
-
Promise Fulfilled next decade of cell gene RNA therapies
-
Promising New Developments in Artificial Intelligence
-
Proprietary IQVIA Digital Health Data Assets and Expertise for Decision Making
-
Putting Patient Perspectives at the heart of cancer care
-
PV AI Automation Tools You Can Deploy Right Now
-
Quality Maturity for Life Sciences
-
Quarterly Global Transparency Report Snapshot and Update Q1 2019
-
Race for Immunity Exploring the Evolving Landscape of the Vaccines Market
-
Radiation Therapy Quality Assurance Clinical Trials
-
Re thinking the Life Sciences Business Model
-
Ready for a Challenge Pressure testing Asset Performance in a Changing Market Environment
-
Real World Data for Value Differentiation in Multiple Myeloma
-
Real World Database Studies Eight Key Steps to Success
-
Real World Evidence is Key to Better Understanding COVID 19 Vaccines
-
Realising The Commercial Promise Of Europe For Emerging Biopharma
-
Reap the benefits of subject matter experts without Expanding Your Internal Teams
-
Rebooting Consumer Health Thriving in the post COVID-19 world
-
Recall Readiness for MedTech Companies
-
Recruiting Rare Disease Patients Just Got Easier
-
Redefining OPEX modelling for a competitive future
-
Redefining Post Market Surveillance
-
Reduce Supplier Risk Reduce Organizational Risk
-
Regulations and Reimbursement for Software as a Medical Device in Europe Part 3
-
Regulations and Reimbursement of Software as a Medical Device in Europe Part 1
-
Regulations and Reimbursement of Software as a Medical Device in Europe Part 2
-
Regulatory and Safety Integration An Integrated Model Approach to Improve the Management of Marketed
-
Reimagining Cancer Care
-
Reimagining Incentive Compensation in a Post-COVID World
-
Remedy of the Commons
-
Renewed Interest in Clinical Research Helps Change the Conversation about Trial Participation
-
Reporting of Medicine Shortages in Europe
-
Riding Out the Storm The Future of Post Pandemic Customer Engagement
-
Right Sized RBM Solution For Your Trials
-
Rising to the challenge
-
Risks to Sponsors Developing and Running Their Own DCT Technology
-
Routes to Sponsor of Choice From Shared Pipelines to Streamlined Payments
-
RWE From Nice To Have to Must Have
-
Salesforce What a Difference a Decade Makes
-
Satisfaction With Treatment
-
Seal of Approval Accelerating Regulatory Success with RWE
-
Segmentation Strategies for Commercial Forecasting
-
Seizing Opportunities Overcoming the Challenges of Decentralized Clinical Trials in Asia Pacific
-
Seizing the potential of outsourcing
-
Selecting Real World Data
-
Selecting The Right NLP Text Analytics Solution For Your Business
-
Self-Driving CAR The Promise of In Vivo CAR T Therapy for Hematologic Malignancies
-
Shifting Data Closer To The Patient
-
Signature Requirements for the eTMF
-
Simpler Faster and More Robust
-
Sky High Inflation and the Great Resignation The Impact on Clinical Site Budgeting
-
Smart Factory Smart Quality Management
-
Source and select the right RWD for your research questions
-
Sourcing Real World Data
-
Steps Towards Addressing Antimicrobial Resistance
-
Sticking Point Developing and Retaining Value with Parenteral Products
-
Strategic Meetings Management The Next Generation
-
Strategically Align New Datasets With Your Organizational Goals
-
Strategies to Achieve Labeling Harmonization Amid a Legal Entity Change
-
Study Start-Up Challenges Hard Realities Effective Strategies
-
Success Multiplied Launch Excellence for Multi Indication Assets
-
Super charge your drug safety process
-
Supplier Quality as a Strategic Advantage
-
Sustaining Growth in a Changing Environment
-
Switching from Rx to OTC Next generation switches leveraging real-world data and evidence
-
Switching On the Lights
-
Talking the Patients Language
-
Taming the Complex Clinical-Trial Ecosystem
-
Tap Into Actionable Insights With an Efficient Data Integration Approach
-
Tapping into APAC Potential for Obesity Clinical Trials
-
Tariffs Trade and Transformation
-
Technology Cannot Replace People
-
Technology disruption in the IVD arena
-
Technologys Role in Addressing Potential Drug Safety Risks
-
Telemedicine Demystified Necessity During the Pandemic Boon for the Future
-
Tender Benchmark survey results 2019 Report 1 The Tender Organization
-
Tender Benchmark survey results 2019 Report 2 Current Tender Environment And Awarding Criteria
-
Tender Benchmark survey results 2019 Report 3 Tendering IT Solutions
-
Tender Benchmark survey results 2019 Report 4 tender management challenges
-
The Answer To Your Pharmacovigilance Challenges
-
The Benefits of a Connected Quality and Regulatory Ecosystem
-
The Case for Patient Diversity in Clinical Trials
-
The Case for Quality Management
-
The Daigou Route to China
-
The Digital Workforce in Clinical Operations
-
The Electronic Trial Master File Study Item and Placeholder Analysis
-
The Evolution and Impact of Pulmonary Arterial Hypertension Clinical Trial Educators
-
The Evolution of Data Engineering in Commercial Pharma
-
The Evolution of Regulatory Affairs
-
The Evolution of the HIV Treatment Landscape
-
The Evolving Global Landscape of Genomic Initiatives
-
The Evolving Landscape of Stroke Key Pipeline and Clinical Trial Insights
-
The Evolving Role of Real World Evidence in Oncology HTA Decision Making
-
The Evolving Safety Technology Landscape
-
The Future is Now The Transformation of Regulatory Processes
-
The Future of Clinical Monitoring
-
The Future of Documents
-
The future of EU HTA
-
The Future of Pharmacovigilance
-
The Future of Pharmacovigilance Integrating AI with Drug Safety Systems
-
The Future of Post Market Surveillance
-
The Future of Regulatory Operations
-
The Future of RIM is Cross functional Integration
-
The Future of Safety
-
The Global MedTech Industry Evolving in Turbulent Times
-
The global MedTech industry Rewiring MedTech in a post-pandemic world
-
The Growing Value of RWE
-
The Impact of Biosimilar Competition in Europe
-
The Impact of Biosimilar Competition in Europe 2021
-
The Impact of Biosimilar Competition in Europe 2022
-
The Impact of Biosimilar Competition in Europe 2023
-
The Impact of Biosimilar Competition in Europe 2024
-
The Impact of Biosimilar Competition in Europe 2025
-
The Impact Of COVID19 on Real World Health Data and Research
-
The Impact of Generative AI in Quality Management
-
The Increasing Impact of Real World Evidence Platforms and Their Future Potential
-
The Next Frontier of Drug Safety Innovation
-
The Next Generation of Information Management
-
The Next Wave of Self-Care Digital Health
-
The Power of Remote Personal Interactions
-
The Power of the Patient Perspective
-
The Rise of Pharmas Chief Orchestration Officer
-
The Rise of Robotics in Orthopedics
-
The Role of Quality Management in Design Control for Medical Device Manufacturers
-
The Scientific Risks of Commoditizing eCOA
-
The Secret Sauce in Successful Clinical Trial Payments Programs
-
The Shifting Paradigm of Dose Selection in Oncology
-
The Smarter Commercial Ecosystem for Life Science Teams
-
The State of Materiovigilance
-
The Top Trends Driving Agility in Commercial Compliance
-
The Truth About Conversational AI
-
The Unique Value of Integrated Safety Services and Technology
-
The value of commercially focused QARA solutions in global medtech
-
The Value of Orchestrated Customer Engagement for Life Science Companies
-
Their Finest Hour Medical Affairs in a Disrupted World
-
Top Five Reasons You Need IRT Expertise Not Just Software
-
Toward an Orchestrated Commercial Ecosystem
-
Training to the Endpoint
-
Transcending the Traditional Focus of Oncology Commercialisation
-
Transform Your Approach To Compliance
-
Transformation of Patient Journey in the Digital
-
Transforming Cancer Treatment
-
Transforming Clinical Trial Design Development with Digital Innovation
-
Transforming Patient Recruitment Through Patient and Site Engagement
-
Transforming patient support services
-
Transforming The Computer Systems Validation For Your QMS Through Automation
-
Transforming the Influence Landscape in Life Sciences and MedTech
-
Transforming Weight Management Trials through Digital Health Technology
-
Transforming Your Organization with a Fully Integrated eQMS Executive Summary
-
Trustworthy AI ML for Patient Analytics and Research
-
Turn Insight into Action with Connected Intelligence
-
Two Steps Forward One Step Back The Long Road to Success in CNS
-
UDI Requirements The Fear Of The Unknown Executive Summary
-
Uncovering Best Practices in Med Tech Sales and Marketing
-
Under the Skin Dermocosmetics 2022
-
Understanding Net Pharmaceutical Expenditure Dynamics in Europe
-
Understanding the Safety Strategies and Regulatory Considerations of Drug Development
-
Unlock the Potential of AI ML with Decision Intelligence
-
Unlocking Consumer Insights with Scientific RWE Surveys
-
Unlocking Global Category Success in Consumer Health
-
Unlocking Growth Potential
-
Unlocking Regulatory Complexities
-
Unlocking the Potential of RWD in Nash
-
Update on COVID 19 Pandemic in China
-
US Pharmaceutical Market Trend Report
-
Usability Studies Evaluating the Human Factor in Cardiovascular Device Usage
-
Using AI & Machine Learning to Drive Commercial Success in the EU
-
Using Artificial Intelligence to Predict Disease Progression
-
Using Behavioral Science to Drive Field Performance
-
Using Connected Intelligence to Improve Decision Making Part 3
-
Using Connected Intelligence to Improve and Accelerate Decision Making Part 4
-
Using Connected Intelligence to Improve Decision Making Part 1
-
Using Connected Intelligence to Improve Decision Making Part 2
-
Using regulatory intelligence to meet MedTech s global challenges
-
Value to Outcomes
-
Venue Preparedness InPerson Promotional Programming prepare safe effective compliant HCP engagements
-
Virtual Real World Research The new normal for consumer health claims generation
-
Virtual Trials 101
-
Vision 2030 patient services and support in the healthcare market of the future
-
What Life Sciences Companies Really Want from IM Vendors
-
Where to Deploy Generative AI Solutions in Life Sciences
-
World Health Organization Prequalification of Vaccines
-